ENDRA Life Sciences EBITDA 2017-2024 | NDRA
ENDRA Life Sciences ebitda from 2017 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| ENDRA Life Sciences Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-11 |
| 2023 | $-10 |
| 2022 | $-13 |
| 2021 | $-11 |
| 2020 | $-11 |
| 2019 | $-8 |
| 2018 | $-8 |
| 2017 | $-4 |
| 2016 | $-1 |
| ENDRA Life Sciences Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-4 |
| 2024-09-30 | $-1 |
| 2024-06-30 | $-2 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-1 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $-3 |
| 2023-03-31 | $-3 |
| 2022-12-31 | $-3 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-4 |
| 2022-03-31 | $-3 |
| 2021-12-31 | $-3 |
| 2021-09-30 | $-3 |
| 2021-06-30 | $-3 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-3 |
| 2020-06-30 | $-3 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $-1 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-3 |
| 2018-12-31 | $-2 |
| 2018-09-30 | $-2 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $-2 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $-1 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.004B | $0.000B |
| ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. | |||